CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo

Publication date: Available online 19 February 2021Source: Microvascular ResearchAuthor(s): Handong Dan, Xinlan Lei, Xin Huang, Ning Ma, Yiqiao Xing, Yin Shen

Source: Microvascular Research - February 19, 2021 Category: Biochemistry Source Type: research